Literature DB >> 31763062

Atrial fibrillation: a leading cause of heart failure-related hospitalizations; a dual epidemic.

Asrar Ahmed1, Waqas Ullah1, Ishtiaq Hussain2, Sohaib Roomi1, Yasar Sattar1,3, Faizan Ahmed1, Rehan Saeed1, Ammar Ashfaq1.   

Abstract

BACKGROUND: Atrial fibrillation (AF), and heart failure (HF) are a major cardiovascular epidemic over the last decade. The prevalence and rehospitalization of heart failure are on rising edge, and many factors are responsible for these re-exacerbations of heart failure. In this study, we sought to determine an association of a risk factor for frequent rehospitalization of heart failure at our institute. We aimed to find the re-admission rate, heart rate, and rhythm of heart failure exacerbation.
METHODS: We performed a single-center retrospective study at the Abington Hospital - Jefferson health and 418 patients having a history of heart failure, and AF were selected. The heart failure readmission rate (days), heart rate, and rhythm were analyzed.
RESULTS: The mean age of the included population was 82.8 years SD ± 9.2. About 53% had AF with a mean heart rate 90 SD ± 21 bpm, and 47% had normal sinus rhythm (NSR) with a mean heart rate of 78 ± 16 bpm on re-admission. This difference was statistically significant (p=0.02). The mean re-admission rate for atrial fibrillation was 27.49 days SD ± 18.97, compared to 32.68 SD ± 20.26 days for NSR, statistically significant (p=0.007) and the Pearson Chi-square was also significant P = 0.006.
CONCLUSION: There is a significantly increased rate of re-admission in heart failure patients with atrial fibrillation with a rapid ventricular rate. Efforts should be taken to keep the patient in NSR or controlled AF to minimize the rehospitalization rate, and this, in turn, reduces the financial burden on patients and institutes. AJCD
Copyright © 2019.

Entities:  

Keywords:  Atrial fibrillation; exacerbation; heart failure; re-hospitalization; treatment

Year:  2019        PMID: 31763062      PMCID: PMC6872464     

Source DB:  PubMed          Journal:  Am J Cardiovasc Dis        ISSN: 2160-200X


  39 in total

Review 1.  Hospitalization epidemic in patients with heart failure: risk factors, risk prediction, knowledge gaps, and future directions.

Authors:  Gregory Giamouzis; Andreas Kalogeropoulos; Vasiliki Georgiopoulou; Sonjoy Laskar; Andrew L Smith; Sandra Dunbar; Filippos Triposkiadis; Javed Butler
Journal:  J Card Fail       Date:  2011-01       Impact factor: 5.712

Review 2.  Atrial fibrillation and heart failure: treatment considerations for a dual epidemic.

Authors:  Elad Anter; Mariell Jessup; David J Callans
Journal:  Circulation       Date:  2009-05-12       Impact factor: 29.690

3.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association.

Authors:  Donald Lloyd-Jones; Robert J Adams; Todd M Brown; Mercedes Carnethon; Shifan Dai; Giovanni De Simone; T Bruce Ferguson; Earl Ford; Karen Furie; Cathleen Gillespie; Alan Go; Kurt Greenlund; Nancy Haase; Susan Hailpern; P Michael Ho; Virginia Howard; Brett Kissela; Steven Kittner; Daniel Lackland; Lynda Lisabeth; Ariane Marelli; Mary M McDermott; James Meigs; Dariush Mozaffarian; Michael Mussolino; Graham Nichol; Véronique L Roger; Wayne Rosamond; Ralph Sacco; Paul Sorlie; Véronique L Roger; Randall Stafford; Thomas Thom; Sylvia Wasserthiel-Smoller; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2009-12-17       Impact factor: 29.690

4.  The progression from hypertension to congestive heart failure.

Authors:  D Levy; M G Larson; R S Vasan; W B Kannel; K K Ho
Journal:  JAMA       Date:  1996 May 22-29       Impact factor: 56.272

5.  Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction: results from the Candesartan in Heart failure-Assessment of Reduction in Mortality and morbidity (CHARM) program.

Authors:  Lars G Olsson; Karl Swedberg; Anique Ducharme; Christopher B Granger; Eric L Michelson; John J V McMurray; Margareta Puu; Salim Yusuf; Marc A Pfeffer
Journal:  J Am Coll Cardiol       Date:  2006-04-27       Impact factor: 24.094

6.  Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial.

Authors:  Shannon M Dunlay; Mihai Gheorghiade; Kimberly J Reid; Larry A Allen; Paul S Chan; Paul J Hauptman; Faiez Zannad; Aldo P Maggioni; Karl Swedberg; Marvin A Konstam; John A Spertus
Journal:  Eur J Heart Fail       Date:  2010-03-01       Impact factor: 15.534

7.  Heart failure in the general population of men--morbidity, risk factors and prognosis.

Authors:  L Wilhelmsen; A Rosengren; H Eriksson; G Lappas
Journal:  J Intern Med       Date:  2001-03       Impact factor: 8.989

8.  Relationships between sinus rhythm, treatment, and survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study.

Authors:  Scott D Corley; Andrew E Epstein; John P DiMarco; Michael J Domanski; Nancy Geller; H Leon Greene; Richard A Josephson; Joyce C Kellen; Richard C Klein; Andrew D Krahn; Mary Mickel; L Brent Mitchell; Joy Dalquist Nelson; Yves Rosenberg; Eleanor Schron; Lynn Shemanski; Albert L Waldo; D George Wyse
Journal:  Circulation       Date:  2004-03-08       Impact factor: 29.690

9.  A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: a propensity-matched study.

Authors:  Mustafa I Ahmed; Michel White; O James Ekundayo; Thomas E Love; Inmaculada Aban; Bo Liu; Wilbert S Aronow; Ali Ahmed
Journal:  Eur Heart J       Date:  2009-06-16       Impact factor: 29.983

10.  Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure.

Authors:  Joel B Braunstein; Gerard F Anderson; Gary Gerstenblith; Wendy Weller; Marlene Niefeld; Robert Herbert; Albert W Wu
Journal:  J Am Coll Cardiol       Date:  2003-10-01       Impact factor: 24.094

View more
  5 in total

Review 1.  Current progress of computational modeling for guiding clinical atrial fibrillation ablation.

Authors:  Zhenghong Wu; Yunlong Liu; Lv Tong; Diandian Dong; Dongdong Deng; Ling Xia
Journal:  J Zhejiang Univ Sci B       Date:  2021-10-15       Impact factor: 3.066

2.  Rhythm Control of Persistent Atrial Fibrillation in Systolic Heart Failure: A Bayesian Network Meta-Analysis of Randomized Controlled Trials.

Authors:  Dibbendhu Khanra; Saurabh Deshpande; Anindya Mukherjee; Siddhratha Mohan; Hassan Khan; Sanjeev Kathuria; Danesh Kella; Deepak Padmanabhan
Journal:  Int J Heart Fail       Date:  2021-06-11

3.  Same Day versus Overnight Discharge in Patients Undergoing Ablation for Atrial Fibrillation (SODA) Study.

Authors:  Som Aftabi Bailey; Karthik Subramanian; Javier Sanchez; Rodney P Horton; Andrea Natale; Senthil Thambidorai
Journal:  J Atr Fibrillation       Date:  2021-08-31

4.  Sex Differences in the Association between Atrial Fibrillation and 90-Day Adverse Outcomes among Older Adults with Heart Failure: A Retrospective Cohort Study.

Authors:  Youn-Jung Son; Da-Young Kim; Mi Hwa Won
Journal:  Int J Environ Res Public Health       Date:  2021-02-24       Impact factor: 3.390

5.  Clinical Characteristics and Factors Associated with Heart Failure Readmission at a Tertiary Hospital in North-Eastern Tanzania.

Authors:  Abid M Sadiq; Nyasatu G Chamba; Adnan M Sadiq; Elichilia R Shao; Gloria A Temu
Journal:  Cardiol Res Pract       Date:  2020-04-30       Impact factor: 1.866

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.